Stock Price Quote

POLY MEDICURE LTD.

NSE : POLYMEDBSE : 531768ISIN CODE : INE205C01021Industry : Medical Equipment/Supplies/AccessoriesHouse : Private
BSE2212.40-43.85 (-1.94 %)
PREV CLOSE ( ) 2256.25
OPEN PRICE ( ) 2220.10
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 16047
TODAY'S LOW / HIGH ( )2125.05 2256.25
52 WK LOW / HIGH ( )1373 3350
NSE2217.40-36.25 (-1.61 %)
PREV CLOSE( ) 2253.65
OPEN PRICE ( ) 2253.95
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 2217.40 (2)
VOLUME 340816
TODAY'S LOW / HIGH( ) 2125.45 2269.95
52 WK LOW / HIGH ( )1373 3357.8
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 30-03 1995
Management Info
Devendra Raj Mehta - Chairman Himanshu Baid - Managing Director
Registered Office

Address 232- B, 3rd Floor,Okhla Industrial Estate,Phase I I I,
New Delhi,
Delhi-110020

Phone 011 - 33550700 / 47317000 / 26321838, 81, 89, 93

Email info@polymedicure.com

Website www.polymedicure.com

Registrars Details
MAS Services Ltd
T-34 , 2nd Floor,Okhla Industrial Area,Phase - II,New Delhi
Listing : BSE, NSE

NEWS

06Feb Poly Medicure incorporates wholly owne
Poly Medicure has incorporated a wholly owned Step-down subsidiary ‘Poly..
03Feb Poly Medicure informs about unaudited
Pursuant to Regulation 30 and 33 of SEBI (LODR) Regulations, 2015, Poly..
10Jan Poly Medicure enters into JV agreement
Poly Medicure has entered into Joint Venture (JV) agreement with AMPIN C..
24Jul Poly Medicure informs about investor p
Poly Medicure has informed that it enclosed the investor's presentation..
17Jan Poly Medicure informs about board meet
Poly Medicure has informed that a meeting of the Board of Directors of t..

Financials

in Millions
QTR Dec 24 ANNUAL 24
Net Profit851.5100000000012517.24
Gross Profit 1133.89 3348.94
Operating Profit 1373.494076.87
Net Sales 4109.3713072.49

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Transpact Enterprise (BSE)
peergroup  145.90 (9.70%)
M.Cap ( in Cr)5.64
Centenial Surgical (BSE)
peergroup  140.00 (3.32%)
M.Cap ( in Cr)51.08
Raaj Medisafe India (BSE)
peergroup  67.00 (4.69%)
M.Cap ( in Cr)88.52
Shree Pacetronix (BSE)
peergroup  80.00 (2.51%)
M.Cap ( in Cr)29.16
Nureca Ltd. (BSE)
peergroup  276.00 (0.55%)
M.Cap ( in Cr)277.00

Shareholding Pattern

MUTUAL FUNDS/UTI 7.17%
PROMOTERS 62.44%
FI/BANKS/INSURANCE 2.44%
NON-INSTITUTION 13.57%
GOVERNMENT 0%
FII 0%

About Poly Medicure Ltd.

Poly Medicure Ltd. was incorporated in the year 1995. Its today's share price is 2212.4. Its current market capitalisation stands at Rs 22533.83 Cr. In the latest quarter, company has reported Gross Sales of Rs. 13125.14 Cr and Total Income of Rs.13654.26 Cr. The company's management includes Vishal Gupta, Ravi Prakash, Avinash Chandra, Rishi Baid, Himanshu Baid, Vimal Bhandari, Alessandro Balboni, Mukulika Baid, Jugal Kishore Baid, Ambrish Mithal, Sonal Mattoo, Amit Khosla, Sandeep Bhargava, Shailendra Raj Mehta, Devendra Raj Mehta .

It is listed on the BSE with a BSE Code of 531768 , NSE with an NSE Symbol of POLYMED and ISIN of INE205C01021. It's Registered office is at 232- B, 3rd Floor,Okhla Industrial Estate,Phase I I INew Delhi-110020, Delhi. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are Doogar & Associates, MC Bhandari & Co

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.